FWATX
Price
$15.72
Change
-$0.02 (-0.13%)
Updated
Oct 17 closing price
Net Assets
3.15B
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

FWATX vs RLBCX

Header iconFWATX vs RLBCX Comparison
Open Charts FWATX vs RLBCXBanner chart's image
Fidelity Advisor Multi-Asset Income A
Price$15.72
Change-$0.02 (-0.13%)
VolumeN/A
Net Assets3.15B
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
FWATX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
FWATX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWATX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. FWATX (3.15B). FWATX pays higher dividends than RLBCX: FWATX (3.51) vs RLBCX (1.49). FWATX was incepted earlier than RLBCX: FWATX (10 years) vs RLBCX (23 years). FWATX (1.09) is less costly to investors than RLBCX (0.89). FWATX is a more actively managed with annual turnover of: 230.00 vs. RLBCX (44.00). FWATX has a lower initial minimum investment than RLBCX: FWATX (0) vs RLBCX (250). FWATX annual gain was more profitable for investors over the last year : 13.78 vs. RLBCX (8.34). FWATX return over 5 years is better than : 52.53 vs. RLBCX (40.24).
FWATXRLBCXFWATX / RLBCX
Total Expense Ratio1.090.89122%
Annual Report Gross Expense Ratio1.090.89122%
Fund Existence10 years23 years-
Gain YTD14.70514.364102%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.15B265B1%
Annual Yield % from dividends3.511.49236%
Returns for 1 year13.788.34165%
Returns for 3 years44.1149.2690%
Returns for 5 years52.5340.24131%
Returns for 10 years115.6772.18160%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals